Vote Scores

Home / Companies / Shanghai Pharmaceuticals Holding Co., Ltd. / 26 Jun 2025

Meeting · year to 30 June 202542 filers reporting

Shanghai Pharmaceuticals Holding Co., Ltd.: meeting of 26 Jun 2025

Votes reported on Form N-PX, item by item

42 Form N-PX filers reported votes at the Shanghai Pharmaceuticals Holding Co., Ltd. meeting of 26 Jun 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

100 vote records from 42 filers. 0 of the 42 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management42 filers100.0% for0.0% against0.0% against management47,395,551 reported shares
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

10 vote records from 3 filers. 3 of the 3 filers that marked the item either way voted against management.

0.0% for100.0% against100.0% against management3 filers0.0% for100.0% against100.0% against management2,564,606 reported shares, counted once per item in this group
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

1,586 vote records from 42 filers. 3 of the 42 filers that marked the item either way voted against management.

90.5% for9.5% against7.1% against management42 filers90.6% for9.4% against9.4% against management797,515,509 reported shares, counted once per item in this group
4

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

339 vote records from 35 filers. 0 of the 35 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management35 filers100.0% for0.0% against0.0% against management180,628,869 reported shares, counted once per item in this group
5

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

41 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers100.0% for0.0% against0.0% against management3,007,200 reported shares, counted once per item in this group

How the largest families voted

Family1. Auditor
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
American CenturyFor
Franklin TempletonFor
Charles SchwabFor
Nuveen and TIAAFor
John Hancock and ManulifeFor
Morgan Stanley, Eaton Vance and CalvertFor
J.P. MorganFor
WisdomTreeFor
Jackson National fundsFor
Northern Trust and FlexSharesFor
ThriventFor
Lincoln FinancialFor
VoyaFor
BNY MellonFor
PIMCOFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Shanghai Pharmaceuticals Holding Co., Ltd. meeting?

42 Form N-PX filers reported votes at the meeting of 26 Jun 2025. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Shanghai Pharmaceuticals Holding Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Shanghai Pharmaceuticals Holding Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Shanghai Pharmaceuticals Holding Co., Ltd. with a meeting date within three days of 26 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.